Protocol summary

Study aim
Determination of the effect of 2 different doses of dexmedetomidine intranasal on cardiovascular response to laryngoscopy and endotracheal intubation
Design
Clinical trial with control group, triple blind, randomized, phase 3 on 90 patients
Settings and conduct
The study of a triple blind randomized clinical trial with a control group during the years 1401-1400 Will be performed at Al-Zahra Medical Center in Isfahan. The person collecting the information does not know the study group, nor does the statistician Does not know the study group
Participants/Inclusion and exclusion criteria
Inclusion criteria: Age 18-65 years II, I ASA (American Anesthesia Association classification based on patients' physical condition) without airway anomaly, elective surgery Inclusion criteria: History of drug sensitivity, pregnancy, Difficult airway , ECG block, BMI> 30, history of obstruction Nasopharyngeal ducts
Intervention groups
Group 1: 1 µg/kg intranasal dexmedetomidine at a concentration of 100 µg/ml in a 1cc syringe after injection of anesthetic drug. Group 2: 2 µg/kg intranasal dexmedetomidine at a concentration of 100 µg/ml in a 1cc syringe after injection of anesthetic drug. Group 3: Normal saline with a volume equivalent to groups 1 and 2 intranasally.
Main outcome variables
Heart rate, systolic blood pressure, diastolic blood pressure, Mean arterial pressure, percentage of oxygen saturation

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20220424054628N1
Registration date: 2022-04-30, 1401/02/10
Registration timing: prospective

Last update: 2022-04-30, 1401/02/10
Update count: 0
Registration date
2022-04-30, 1401/02/10
Registrant information
Name
Zahra Maghsoudi
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 31 3662 4796
Email address
zahra.m7596@gmail.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2022-05-21, 1401/02/31
Expected recruitment end date
2022-11-21, 1401/08/30
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
The effect of two different doses of dexmedetomidine intranasal on the cardiovascular response to laryngoscopy and endotracheal intubation
Public title
The effect of dexmedetomidine on cardiovascular response
Purpose
Prevention
Inclusion/Exclusion criteria
Inclusion criteria:
Elective surgery No airway abnormalities Requires endotracheal intubation under general anesthesia
Exclusion criteria:
History of allergy to the studied drug Difficult Airway Heart block in ECG BMI>30 History of obstruction of the nasopharyngeal ducts Pregnancy
Age
From 18 years old to 65 years old
Gender
Both
Phase
3
Groups that have been masked
  • Participant
  • Care provider
  • Investigator
  • Outcome assessor
  • Data analyser
Sample size
Target sample size: 90
Randomization (investigator's opinion)
Randomized
Randomization description
In this study, the simple randomization method of block randomization (block randomization) we will use. Blocking is usually in order Balance the number of samples assigned to each group To be used in the study. This feature helps researchers to Items that require intermediate analyzes during the sampling process The number of samples assigned to each of the case groups Study is equal. The size of all the blocks is equal and we are in this We will have a three-group trial of 6 blocks of 15. Randomization tools are also used in sequence generation software Random (software allocation Random) is used that Random sequence generation software in addition to simple randomization capable To generate random sequences by block generation method. For hiding We avoid concealment allocation We use the method used to execute the sequence Random refers to study participants, in a way That before the individual is assigned, the assigned group is not specified. With From opaque envelopes sealed in random sequence (envelopes opaque, sealed, numbered Sequentially) in This method uses each of the random sequences created on a card It is registered and the cards are placed in the letter envelopes in order To be. In order to maintain a random sequence, also on the outer surface of the envelope The numbering is done in the same way. Finally the envelope lid The letters are pasted and placed in a box, respectively. At Time to start registration of participants, based on the order of entry of the company Eligible applicants to open one of the envelopes in order And the assigned group of the participant will be revealed.
Blinding (investigator's opinion)
Triple blinded
Blinding description
The researcher, patients and project partner who will perform the statistical analysis will not be aware of the study (triole blind). The grouping of patients will be recorded on a sheet and given to one of the project colleagues.
Placebo
Used
Assignment
Factorial
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics committee of Isfahan University of Medical Sciences
Street address
Isfahan University of Medical Sciences, Hezar Jerib St., Azadi Square
City
Isfahan
Province
Isfehan
Postal code
8164945813
Approval date
2022-01-17, 1400/10/27
Ethics committee reference number
IR.MUI.MED.REC.1400.748

Health conditions studied

1

Description of health condition studied
Cardiovascular response after laryngoscopy and tracheal intubation
ICD-10 code
ICD-10 code description

Primary outcomes

1

Description
Heart Rate
Timepoint
before induction of anesthesia and minutes 1, 3, 5, 10
Method of measurement
Cardiac monitor device

2

Description
Systolic blood pressure
Timepoint
before induction of anesthesia and minutes 1, 3, 5, 10
Method of measurement
In millimeters of mercury using a calibrated barometer

3

Description
Diastolic blood pressure
Timepoint
before induction of anesthesia and minutes 1, 3, 5, 10
Method of measurement
In millimeters of mercury using a calibrated barometer

4

Description
mean arterial pressure
Timepoint
before induction of anesthesia and minutes 1, 3, 5, 10
Method of measurement
In millimeters of mercury using a calibrated barometer

5

Description
Percentage of oxygen saturation
Timepoint
before induction of anesthesia and minutes 1, 3, 5, 10
Method of measurement
Pulse oximeter

Secondary outcomes

1

Description
hypotension
Timepoint
Before induction of anesthesia, minutes 1, 3, 5, 10
Method of measurement
In millimeters of mercury using a calibrated barometer

2

Description
hypertension
Timepoint
Before induction of anesthesia, minutes 1, 3, 5, 10
Method of measurement
In millimeters of mercury using a calibrated barometer

3

Description
bradycardia
Timepoint
Before induction of anesthesia, minutes 1, 3, 5, 10
Method of measurement
Cardiac monitor device

4

Description
tachycardia
Timepoint
Before induction of anesthesia, minutes 1, 3, 5, 10
Method of measurement
Cardiac monitor device

Intervention groups

1

Description
Intervention group: 1 µg / kg dexmedetomidine intranasal at a concentration of 100 µg / ml in a 1cc syringe after injection of anesthetic drug
Category
Prevention

2

Description
Intervention group: 2 µg / kg dexmedetomidine intranasal at a concentration of 100 µg / ml in a 1cc syringe after injection of anesthetic drug
Category
Prevention

3

Description
Control group: Normal saline with a volume equivalent to groups 1 and 2 intranasally
Category
Placebo

Recruitment centers

1

Recruitment center
Name of recruitment center
Al-Zahra hospital
Full name of responsible person
azim honarmand
Street address
Al-Zahra Hospital, Isfahan University of Medical Sciences, Hezar Jerib St., Azadi Square
City
Isfahan
Province
Isfehan
Postal code
8164945812
Phone
+98 31 3662 4796
Email
honarmand@med.mui.ac.ir

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Esfahan University of Medical Sciences
Full name of responsible person
mojgan mortazavi
Street address
Isfahan University of Medical Sciences., Hezar Jarib St., Azadi Square
City
Isfahan
Province
Isfehan
Postal code
8164945811
Phone
+98 31 3662 4796
Email
mortazavi@med.mui.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Esfahan University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Esfahan University of Medical Sciences
Full name of responsible person
Azim Honarmand
Position
professor
Latest degree
Subspecialist
Other areas of specialty/work
Anesthesiology
Street address
Al-Zahra Hospital, Isfahan University of Medical Sciences, Hezar Jerib St., Azadi Square
City
Isfahan
Province
Isfehan
Postal code
8164945811
Phone
+98 31 3662 4796
Fax
Email
honarmand@med.mui.ac.ir

Person responsible for scientific inquiries

Contact
Name of organization / entity
Esfahan University of Medical Sciences
Full name of responsible person
Azim Honarmand
Position
professor
Latest degree
Subspecialist
Other areas of specialty/work
Anesthesiology
Street address
Al-Zahra Hospital, Isfahan University of Medical Sciences, Hezar Jerib St., Azadi Square
City
Isfahan
Province
Isfehan
Postal code
8164945811
Phone
+98 31 3662 4796
Fax
Email
honarmand@med.mui.ac.ir

Person responsible for updating data

Contact
Name of organization / entity
Esfahan University of Medical Sciences
Full name of responsible person
Zahra Maghsoudi
Position
Medical intern
Latest degree
A Level or less
Other areas of specialty/work
General Practitioner
Street address
Faculty of Medicine, Isfahan University of Medical Sciences, Hezar Jerib St., Azadi Square
City
Isfahan
Province
Isfehan
Postal code
8164945812
Phone
+98 31 3662 4796
Fax
Email
Zahra.m7596@gmail.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Yes - There is a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Title and more details about the data/document
Information on the effectiveness of dexmedetomidine on the cardiovascular response
When the data will become available and for how long
Start the access period up to one year after the results are published
To whom data/document is available
Researchers
Under which criteria data/document could be used
Can be used for secondary studies.
From where data/document is obtainable
Correspond with honarmand@mui.ac.ir.
What processes are involved for a request to access data/document
Will be sent after receiving the email.
Comments
Loading...